Langerhans' cell histiocytosis of the temporal bone: A case report

Ni,Maomei; Yang,Xiuhai

doi:10.3892/etm.2017.4072

Langerhans' cell histiocytosis of the temporal bone: A case report

Authors:
- Maomei Ni
- Xiuhai Yang
View Affiliations

Affiliations: Department of Otorhinolaryngology, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China
Published online on: January 20, 2017 https://doi.org/10.3892/etm.2017.4072
Pages: 1051-1053

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Langerhansmporal histiocytosis (LCH) refers to a group of diseases that are characterized by the primary pathogenesis of an abnormal polyclonal proliferation of Langerhans cells that affect different structures of the human body, including the temporal bone. Thus far, the etiology of LCH remains unclear. Diagnosis of LCH is based on a synthetic analysis of the clinical presentations, as well as on features of imaging and histopathology. The clinical features, diagnosis, treatment and prognosis of LCH remain obscure, and temporal LCH is often confused with ear inflammatory lesions and malignant tumors. There are several therapeutic modalities for temporal bone LCH that include surgery, chemotherapy, radiotherapy and steroidal injections. The present study reports the case of an infant presenting a 1‑month history of worsening left facial paralysis and a slowly enlarging post auricular mass followed by a 1‑month history of postauricular swelling in the left ear. Computed tomography demonstrated a large mass of organized tissue. Moreover, the diagnosis of LCH was confirmed by histopathological and immunohistochemical examinations. The patient also suffered from multiple organ failure, including the liver, kidney, lymphatic system, skin, hematopoietic system and lungs. Following surgical intervention with mastoidotympanectomy, the parents of the patient refused further chemotherapy, and the patient succumbed to the disease ~6 months later.

View Figures

View References

1	Campos MK, Viana MB, de Oliveira BM, Ribeiro DD and Silva CM: Langerhans cell histiocytosis: A 16-year experience. J Pediatr (Rio J). 83:79–86. 2007. View Article : Google Scholar : PubMed/NCBI
2	Weintraub M, Bhatia KG, Chandra RS, Magrath IT and Ladisch S: p53 expression in Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 20:12–17. 1998. View Article : Google Scholar : PubMed/NCBI
3	Saliba I, Sidani K, El Fata F, Arcand P, Quintal MC and Abela A: Langerhans' cell histiocytosis of the temporal bone in children. Int J Pediatr Otorhinolaryngol. 72:775–786. 2008. View Article : Google Scholar : PubMed/NCBI
4	Cochrane LA, Prince M and Clarke K: Langerhans' cell histiocytosis in the paediatric population: Presentation and treatment of head and neck manifestations. J Otolaryngol. 32:33–37. 2003. View Article : Google Scholar : PubMed/NCBI
5	DiNardo LJ and Wetmore RF: Head and neck manifestations of histiocytosis-X in children. Laryngoscope. 99:721–724. 1989. View Article : Google Scholar : PubMed/NCBI
6	Irving RM, Broadbent V and Jones NS: Langerhans' cell histiocytosis in childhood: Management of head and neck manifestations. Laryngoscope. 104:64–70. 1994. View Article : Google Scholar : PubMed/NCBI
7	Kleinjung T, Woenckhaus M, Bachthaler M, Wolff JE and Wolf SR: Langerhans' cell histiocytosis with bilateral temporal bone involvement. Am J Otolaryngol. 24:265–270. 2003. View Article : Google Scholar : PubMed/NCBI
8	Vezina JP, Audet N and Fradet G: Cerebrospinal fluid otorrhoea: A rare presentation of Langerhans' cell histiocytosis of the temporal bone. J Laryngol Otol. 124:545–548. 2010. View Article : Google Scholar : PubMed/NCBI
9	Grant GA, Kim DK, Shaw CM and Berger MS: Solitary eosinophilic granuloma of the temporal lobe: Case report and review of the literature. Brain Tumor Pathol. 16:55–59. 1999. View Article : Google Scholar : PubMed/NCBI
10	Isaacs H Jr: Fetal and neonatal histiocytoses. Pediatr Blood Cancer. 47:123–129. 2006. View Article : Google Scholar : PubMed/NCBI
11	Ha SY, Helms P, Fletcher M, Broadbent V and Pritchard J: Lung involvement in Langerhans' cell histiocytosis: Prevalence, clinical features, and outcome. Pediatrics. 89:466–469. 1992.PubMed/NCBI
12	Nanduri VR, Pritchard J, Chong WK, Phelps PD, Sirimanna K and Bailey CM: Labyrinthine involvement in Langerhans' cell histiocytosis. Int J Pediatr Otorhinolaryngol. 46:109–115. 1998. View Article : Google Scholar : PubMed/NCBI
13	Ha SY, Helms P, Fletcher M, Broadbent B and Pritchard J: Lung involvement in Lanerhans' cell histiocytosis: Prevalence, clinical features, and outcome. Pediatrics. 89:466–469. 1992.PubMed/NCBI
14	Chen L, Wang WQ, Xu H and Chi FL: Langerhans cell histiocytosis of the temporal bone: 22 cases analysis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 45:212–216. 2010.(In Chinese). PubMed/NCBI
15	Brown CW, Jarvis JG, Letts M and Carpenter B: Treatment and outcome of vertebral Langerhans cell histiocytosis at the Children's Hospital of Eastern Ontario. Can J Surg. 48:230–236. 2005.PubMed/NCBI
16	Herwig MC, Wojno T, Zhang Q and Grossniklaus HE: Langerhans cell histiocytosis of the orbit: Five clinicopathologic cases and review of the literature. Surv Ophthalmol. 58:330–340. 2013. View Article : Google Scholar : PubMed/NCBI
17	Kasper EM, Aguirre-Padilla DH, Alter RY and Anderson M: Histiocytosis X: Characteristics, behavior, and treatments as illustrated in a case series. Surg Neurol Int. 2:572011. View Article : Google Scholar : PubMed/NCBI
18	de Barros Fernandes Humberlo, Granjeiro RC and de Negreiros Júnior J: Langerhans Cell Histiocytosis in Otorhinolaryngology. 13:444–449. 2009.
19	Bayazit Y, Sirikci A, Bayaram M, Kanlikama M, Demir A and Bakir K: Eosinophilic granuloma of the temporal bone. Auris Nasus Larynx. 28:99–102. 2001. View Article : Google Scholar : PubMed/NCBI
20	Mosnier I, Rondini-Gilli E, Crosara PT, Belmatoug N, Cyna-Gorse F, Cazals-Hatem D, Abbey-Toby A, Bozorg-Grayeli A and Sterkers O: Langerhans' cell histiocytosis of the labyrinth in adults. Otol Neurotol. 25:27–32. 2004. View Article : Google Scholar : PubMed/NCBI
21	Martini A, Aimoni C, Trevisani M and Marangoni P: Langerhans' cell histiocytosis: Report of a case with temporal localization. Int J Pediatr Otorhinolaryngol. 55:51–56. 2000. View Article : Google Scholar : PubMed/NCBI
22	Wu JJ, Huang DB, Pang KR, Hsu S and Tyring SK: Thalidomide: Dermatological indications, mechanisms of action and side-effects. Br J Dermatol. 153:254–273. 2005. View Article : Google Scholar : PubMed/NCBI
23	Dornfeld S, Winkler C, Dörr W and Herrmann T: The radiotherapy of histiocytosis X. A case report of an eosinophilic granuloma in adulthood and a review of the literature. Strahlenther Onkol. 174:534–535. 1998.(In German). View Article : Google Scholar : PubMed/NCBI
24	Heyd R, Strassmann G, Donnerstag F, Martin T and Zamboglou N: Radiotherapy in Langerhans-cell histiocytosis. 2 case reports and review of the literature. Rontgenpraxis. 53:51–61. 1999.(In German).
25	Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH and Schomberg PJ: Langerhans cell histiocytosis: Diagnosis, natural history, management, and outcome. Cancer. 85:2278–2290. 1999. View Article : Google Scholar : PubMed/NCBI